Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma

Por Hu, Ming-Hung, Chen, Li-Ju, Chen, Yen-Lin, Tsai, Ming-Shen, Shiau, Chung-Wai, Chao, Tzu-I, Liu, Chun-Yu, Kao, Jia-Horng, Chen, Kuen-Feng
Publicado no Oncotarget (2017)

Cisplatin-Based Chemotherapy versus Cetuximab in Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer Treatment

Por Hu, Ming-Hung, Wang, Ling-Wei, Lu, Hsueh-Ju, Chu, Pen-Yuan, Tai, Shyh-Kuan, Lee, Tsung-Lun, Chen, Ming-Huang, Yang, Muh-Hwa, Chang, Peter Mu-Hsin
Publicado em 2014

Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation

Por Liu, Yao-Chung, Chien, Sheng-Hsuan, Fan, Nai-Wen, Hu, Ming-Hung, Gau, Jyh-Pyng, Liu, Chia-Jen, Yu, Yuan-Bin, Hsiao, Liang-Tsai, Chiou, Tzeon-Jye, Tzeng, Cheng-Hwai, Chen, Po-Min, Liu, Jin-Hwang
Publicado no Stem Cells Int (2016)

Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells

Por Liu, Chun-Yu, Hu, Ming-Hung, Hsu, Chia-Jung, Huang, Chun-Teng, Wang, Duen-Shian, Tsai, Wen-Chun, Chen, Yi-Ting, Lee, Chia-Han, Chu, Pei-Yi, Hsu, Chia-Chi, Chen, Ming-Huang, Shiau, Chung-Wai, Tseng, Ling-Ming, Chen, Kuen-Feng
Publicado no Oncotarget (2016)

Correction: Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells

Por Liu, Chun-Yu, Hu, Ming-Hung, Hsu, Chia-Jung, Huang, Chun-Teng, Wang, Duen-Shian, Tsai, Wen-Chun, Chen, Yi-Ting, Lee, Chia-Han, Chu, Pei-Yi, Hsu, Chia-Chi, Chen, Ming-Huang, Shiau, Chung-Wai, Tseng, Ling-Ming, Chen, Kuen-Feng
Publicado no Oncotarget (2017)